Enzyme deficient in maple syrup urine disease?
The enzyme defect here is something related to their breakdown. I remember that the branched-chain alpha-keto acid dehydrogenase complex is involved. Wait, that's part of the metabolic pathway for leucine, isoleucine, and valine. If that enzyme is deficient, the amino acids can't be processed properly, leading to the accumulation of their respective alpha-keto acids. That gives the urine that maple syrup smell. So the correct answer should be the deficiency of branched-chain alpha-keto acid dehydrogenase.
Now, looking at the options, the correct one is probably option C or D. But since the user didn't list the options, I'll have to assume standard ones. Common incorrect options might include other enzymes like phenylalanine hydroxylase (which is for PKU), or maybe something like ornithine transcarbamylase. Let me think. The other options would be for different metabolic disorders.
For example, option A might be phenylalanine hydroxylase, which causes phenylketonuria. That's a different disorder. Option B could be isocitrate dehydrogenase, which isn't related here. Option D might be something like pyruvate dehydrogenase, which is another enzyme complex but not specific to branched-chain amino acids.
The clinical pearl here is that maple syrup urine disease is autosomal recessive and presents with the characteristic odor, along with neurological symptoms. Treatment involves dietary restriction of branched-chain amino acids. The key is recognizing the enzyme involved in the breakdown pathway. So the correct answer is the branched-chain alpha-keto acid dehydrogenase complex deficiency.
**Core Concept**
Maple syrup urine disease (MSUD) is an autosomal recessive inborn error of metabolism caused by deficiency of **branched-chain alpha-keto acid dehydrogenase (BCKAD)**, an enzyme complex critical for catabolizing branched-chain amino acids (leucine, isoleucine, valine). Accumulation of their alpha-keto analogs leads to neurotoxicity and the characteristic sweet-smelling urine.
**Why the Correct Answer is Right**
The **BCKAD complex** catalyzes the rate-limiting step in branched-chain amino acid metabolism by decarboxylating their alpha-keto acids. Its deficiency prevents breakdown of leucine, isoleucine, and valine, causing toxic accumulation of corresponding alpha-keto acids (e.g., alpha-ketoisocaproic acid from leucine). This leads to metabolic acidosis, neurological deterioration, and the hallmark "maple syrup" odor due to conjugated byproducts in urine.
**Why Each Wrong Option is Incorrect**
**Option A:** *Phenylalanine hydroxylase* deficiency causes phenylketonuria (PKU), not MSUD.
**Option B:** *Ornithine transcarbamylase* deficiency is an urea cycle disorder causing hyperammonemia.
**Option